Non-Healing Wound Workup: Systematic Approach Case Study

Non-Healing Wound Workup: A Systematic Case Study

A non-healing wound workup is triggered when a wound fails to demonstrate meaningful progress — typically defined as less than 30-40% area reduction over 4 weeks of appropriate treatment. At that inflection point, continuing the same treatment without investigating underlying barriers is not perseverance. It is inertia. Something is preventing this wound from healing, and the clinician's job is to find out what.

This composite case study follows a hypothetical patient through a systematic workup that identifies the barrier to healing. All patient details, clinical findings, and outcomes are composite and hypothetical, created for educational purposes. No real patient data is represented.

---

Initial Scenario: The Stalled Wound

The hypothetical patient is a 67-year-old female with a wound on the lateral left lower leg. She was referred to the wound care practice 6 weeks ago with what appeared to be a traumatic wound — she reported bumping her leg on a coffee table 3 months prior to the initial visit. The wound has been managed with moist wound healing principles: debridement of fibrinous tissue, a collagen dressing with a foam secondary, and weekly follow-up.

Progress to Date

At the initial visit, the wound measured 3.8 cm x 2.9 cm. After 6 weeks of treatment, it measures 3.5 cm x 2.7 cm. That is a 14% area reduction — well below the 40% threshold that predicts healing by 12 weeks. The wound bed shows healthy-appearing granulation tissue. There is no clinical sign of infection (no purulence, no periwound warmth, no increasing pain). The wound simply is not closing.

The clinician documents the stalled trajectory and initiates a systematic non-healing wound workup. This is not a failure of the treatment plan. It is the treatment plan doing exactly what it should: generating data that triggers escalation.

For a comprehensive overview of wound healing barriers, see Why Wounds Don't Heal.

---

The Systematic Workup: Four Domains

Domain 1: Vascular Assessment

Rationale: Inadequate perfusion is the most common treatable barrier to wound healing in the lower extremity. A wound cannot heal if the tissue does not receive adequate oxygen and nutrients.

Workup:

• ABI: 0.88 on the left (borderline low), 0.96 on the right. An ABI below 0.9 warrants further investigation.
• Toe pressures: 58 mmHg on the left (normal > 55 mmHg). This suggests adequate perfusion at the digital level, but the borderline ABI raises concern.
• Duplex ultrasound: Ordered to evaluate for both arterial stenosis and venous reflux. Results show no significant arterial disease. No venous reflux.

Conclusion: Vascular status is adequate for wound healing. The borderline ABI is noted but does not explain the stalled healing trajectory given normal toe pressures and ultrasound findings.

Domain 2: Nutritional Assessment

Rationale: Protein-calorie malnutrition impairs every phase of wound healing. Collagen synthesis requires adequate protein intake and micronutrient availability.

Workup:

• Albumin: 3.7 g/dL (normal). Prealbumin: 21 mg/dL (normal).
• BMI: 26. Adequate body mass.
• Dietary history: The patient reports a varied diet with adequate protein intake. No recent weight loss.
• HbA1c: 5.8% (not diabetic).
• Vitamin D: 28 ng/mL (borderline low, normal > 30). Vitamin D supplementation is initiated, though this alone is unlikely to be the primary healing barrier.

Conclusion: Nutritional status is adequate. No significant deficiencies identified.

Domain 3: Infection and Biofilm Assessment

Rationale: Chronic wounds harbor biofilm — structured communities of bacteria embedded in an extracellular matrix that protects them from host defenses and topical antimicrobials. Biofilm does not always present with classic infection signs.

Workup:

• Clinical signs: No purulence, warmth, or expanding erythema. Mild wound odor.
• Tissue biopsy for culture: Obtained from the wound base using a punch biopsy. Results: polymicrobial growth at 10&sup4; CFU/g — below the 10&sup5; threshold for clinical infection but consistent with biofilm-level colonization.
• Biofilm-targeted treatment trial: A 2-week course of sharp debridement at each visit combined with a biofilm-disrupting wound gel. If the wound responds (resumes healing trajectory), biofilm was likely contributing.

Result of trial: Minimal change. The wound area decreases by 5% over 2 weeks. Biofilm management improved the wound bed appearance but did not meaningfully accelerate closure.

Conclusion: Biofilm is present but is not the primary barrier.

Domain 4: Tissue Biopsy for Atypical Pathology

Rationale: When vascular, nutritional, and infection domains are adequately addressed and the wound still does not heal, atypical pathology must be considered. Non-healing wounds can harbor malignancy (squamous cell carcinoma arising in a chronic wound, known as Marjolin ulcer), vasculitis, pyoderma gangrenosum, or other inflammatory conditions.

Workup:

• Punch biopsy: A 4 mm punch biopsy is obtained from the wound edge (not the wound bed) and sent for histopathological evaluation.
• Results: The biopsy reveals squamous cell carcinoma at the wound margin.

Conclusion: The wound is not healing because it is a malignancy, not a traumatic wound. The original injury (coffee table trauma) may have initiated the wound, but the failure to heal reflects neoplastic transformation at the wound margin.

For guidance on when to reassess treatment strategies for stalled wounds, see When to Stop Treatment.

---

Post-Diagnosis Management

The patient is immediately referred to dermatologic surgery for wide local excision. The wound care clinician:

1. Documents the complete workup timeline showing systematic evaluation before biopsy.
2. Contacts the referring provider to communicate the diagnosis.
3. Continues wound management with non-occlusive dressings pending surgical scheduling.
4. Documents the referral and handoff in the wound care record.

Why the Systematic Approach Mattered

This wound could have been biopsied at week 4. It could have been biopsied at week 1 if the clinician had an index of suspicion. The systematic workup is not designed to delay biopsy — it is designed to ensure that all common, treatable barriers are evaluated before and alongside the consideration of atypical pathology. In clinical practice, vascular disease and malnutrition are far more common causes of non-healing wounds than malignancy. The systematic approach ensures the common causes are not missed while the rare cause is identified.

The key trigger was the 4-week healing trajectory. Without a quantitative measurement of wound area at each visit, the stalled trajectory would have been a clinical impression rather than a data-driven finding. Standardized wound measurement is not just a billing requirement. It is a clinical decision tool.

---

Key Takeaways

• The 4-week rule is a clinical decision trigger, not just a guideline. Less than 30-40% area reduction in 4 weeks of appropriate treatment should initiate a formal non-healing wound workup. Do not wait longer hoping the wound will catch up.
• Work the domains systematically: vascular, nutrition, infection, then atypical pathology. This sequence moves from most common to least common causes and from least invasive to most invasive testing.
• Biopsy the wound edge, not the wound bed. Wound bed biopsies show granulation tissue. Wound edge biopsies capture the transitional zone where atypical pathology (malignancy, vasculitis) is most likely to be identified.
• A wound that looks healthy but does not heal is the most dangerous wound. Healthy granulation tissue with absent epithelial migration is a hallmark of several atypical pathologies. Do not let a clean-looking wound lull you into continued conservative management.
• Document the workup timeline. The systematic approach demonstrates medical decision-making that supports the clinician's judgment, billing, and medicolegal record.